Smart insulin pumps put to the test in everyday life
NCT ID NCT05418699
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 410 people with type 1 diabetes who use closed-loop insulin pumps—devices that automatically adjust insulin delivery. Researchers measured how well these pumps control blood sugar over time using HbA1c levels. The goal was to see if the pumps work effectively outside of controlled research settings.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- closed-loop insulin pump
- What this could lead to
- If successful, this could show that closed-loop pumps improve blood sugar control in real-world settings, helping guide better diabetes management.
- What could go wrong
- This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
410 people
The number who actually took part.
- Started
-
Sep 2022
- Finished
-
Mar 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Type I diabetic patients with a closed-loop insulin pump between April 2020 and August 2023
- Ages
-
7 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * type I diabetic * with a closed-loop insulin pump Exclusion Criteria: * under legal protection order * patient or legal guardian objecting to the use of the data in the research
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Type 1 diabetes are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CH Boulogne-sur-Mer
Boulogne-sur-Mer, France
-
CH Béthune-Beuvry
Béthune, France
-
CH Dax
Dax, France
-
CH Périgueux
Périgueux, France
-
CHI Mont de Marsan et du Pays des Sources
Mont-de-Marsan, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tiny horses, big lessons: can ponies help kids tame diabetes?
- Can a math model tune insulin pumps better than standard care?
- Can a group program stop eating disorders in type 1 diabetes?
- Can a Two-Punch immune therapy save insulin cells in newly diagnosed diabetes?
- Can a smart insulin pump tailored for pregnancy protect mothers and babies?
- Can an automated pancreas system make type 1 diabetes safer in the real world?